Dark triad traits in anabolic steroid users
Their awareness, understanding, and confidence in a new drug can influence how quickly and widely it is adopted in clinical practice
10.1016/j.mayocp.2019.01.001 Mayo Clin
GLP-1s tend to be expensive, but are often covered by insurance
This blog explores three regenerative therapies currently used in clinical practice for EDS, stem cell therapy, platelet-rich plasma (PRP), and prolotherapy, and presents evidence of their benefits for EDS subtypes where they are most applicable
As all eligible cases from the database were included and the sample size was inherently determined by disease incidence, no formal sample size or power calculation was carried out